Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jan 05,2021
Science: “Cancer King” Pancreatic Cancer Finally Has a New Dawn of Treatment
A new study conducted by scientists at the Perelman School of Medicine at the University of Pennsylvania shows that DNA mutations that frequently occur in the development of many pancreatic tumors appear to make these cancers vulnerable to existing drugs called PARP inhibitors. The discovery was published in “Science Progress” recently. Studies have shown thatRead more
More
Dec 29,2020
A New Type of Antibiotic That is not Afraid of Bacterial Infection
Scientists at the Wistar Institute have discovered a new type of compound that can quickly combine antibiotics that directly kill the proliferation of bacteria and protozoa with the immune response to combat antibiotic substitution (AMR). Therefore, the study was published recently in ” Nature. Nature: A new type of antibiotic that is not afraid ofRead more
More
A New Type of Antibiotic That is not Afraid of Bacterial Infection
Dec 25,2020
Seizures Can Also be Predicted a Few Days in Advance Like a Weather Forecast!
Epilepsy is a chronic disease with repeated episodes of convulsions. The short electrical activity of the brain can cause convulsions, hallucinations or loss of consciousness. Seizures are divided into partial/focal seizures, generalized seizures, and unclassified seizures. If the seizure is not treated in time, it may cause great harm to the patient. Recently, a newRead more
More
Dec 24,2020
The Scale of the Drug Discovery CRO Industry Continues to Grow
The development of new drugs is booming, and drug discovery determines the success or failure of drug development. The research and development of new drugs is the source of innovation in the global pharmaceutical industry and is of great significance to human health and life safety. In 2019, the Center for Drug Evaluation and ResearchRead more
More
The Scale of the Drug Discovery CRO Industry Continues to Grow
Dec 23,2020
Small CRO-Opportunities and Challenges of Clinical Research
2017 is so extraordinary For the research and development industry of drugs and medical devices, 2017 is destined to be an extraordinary year. For clinical researchers, this "extraordinary” year is mainly reflected in the following five aspects: More in-depth self-examination After the self-inspection verification announcement was issued on July 22, 2015, regardless of the sponsor,Read more
More
Small CRO-Opportunities and Challenges of Clinical Research
Dec 23,2020
CRO or Not? The Advantages and Disadvantages of Three Choices in Clinical Research
There is no standard answer to the question whether the sponsor establishes a team of monitors to do clinical research or outsources clinical research to CRO. Sponsors often outsource a large number of projects to CROs. After a period of time, they find that there is a problem with the quality of control, and thenRead more
More
CRO or Not? The Advantages and Disadvantages of Three Choices in Clinical Research
Dec 22,2020
The Latest TOP10 Ranking of Global CRO Companies
Former Fierce Markets writer and current independent writer Arsalan Arif recently published the latest top 10 global CRO companies in 2016. Let me share with you here that the ranking is based on market value to find the largest contract research organizaitons. The data source is mainly based on the financial reports of listed companies,Read more
More
Dec 21,2020
What is the CRO Industry?- 63.01 Billion Market Size of the CRO Industry
The CRO industry is an emerging industry developed in China in the past two decades. The pharmaceutical outsourcing industry originated in developed countries in Europe and the United States, but subject to high R&D costs, the industry has gradually shifted to emerging developing countries such as China and India. In 1996, MDS Pharma Service investedRead more
More
Dec 21,2020
TOP 10 New CRO Companies in China
"China's new CRO enterprise innovation technology application index evaluation and TOP10 ranking”, in-depth analysis of China's new CRO enterprise TOP10 innovative technology application and results. CRO (Contract Research Organization), a contract research organization, is an academic or commercial scientific organization that provides professional services for pharmaceutical companies and research institutions in the drug development processRead more
More
TOP 10 New CRO Companies in China
Dec 18,2020
Analysis of the Development Status, Market Size and Market Prospects of the Global CRO Industry in 2020
Analysis of the Development Status of the Global CRO Industry From the perspectives of R&D expenditure and outsourcing rate, the global CRO industry has gradually begun to recover after experiencing a low boom in 2008-2012. ——R&D Expenditure: In recent years, new treatment methods, new drug discovery technologies have continuously emerged, primary market financing has beenRead more
More
Analysis of the Development Status, Market Size and Market Prospects of the Global CRO Industry in 2020
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->